COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Cocrystal Pharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.95−0.07 (-7.20%)
Close on Oct 19, 2026
- Market cap
- $13.05M
- P/E (TTM)
- –
- Dividend yield
- –
Cocrystal Pharma statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Market Cap | $18.23M | $166.30M |
| Enterprise Value | $16.07M | $88.19M |
| PB Ratio | 17.47 | 2.03 |
| P/TBV Ratio | 17.47 | 2.29 |
Income (trailing twelve months)
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Operating Income | -$10.11M | -$21.40M |
| Net Income | -$9.94M | -$22.46M |
| EBITDA | -$10.06M | -$16.91M |
| EPS (Diluted) | -$0.77 | -$0.83 |
Returns
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Return on Equity (ROE) | -311.7% | -53.2% |
| Return on Assets (ROA) | -151.1% | -40.9% |
| Return on Capital Employed (ROCE) | -497.3% | -38.1% |
Balance sheet
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.17M | $61.43M |
| Net Cash (Debt) | $2.17M | $15.35M |
| Net Cash Per Share | $0.11 | $0.66 |
| Equity (Book Value) | $1.04M | $49.09M |
| Book Value Per Share | $0.05 | $1.37 |
| Tangible Book Value | $1.04M | $23.52M |
| Working Capital | $620.00K | $76.81M |
Financial position
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Current Ratio | 1.24 | 3.34 |
| Quick Ratio | 0.83 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Operating Cash Flow | -$7.95M | -$12.35M |
Efficiency
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Profits Per Employee | -$993.80K | -$703.34K |
| Employee Count | 10 | 74 |
Dividends and yields
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Earnings Yield | -54.5% | -23.3% |
Shares
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Shares Outstanding | 19,263,200 | 58,127,000 |
| Shares Change (YoY) | 28.7% | 10.9% |
| Shares Change (QoQ) | 0.01% | 0.54% |
| Float | 7,654,510 | 49,136,700 |
| Shares Held by Insiders | 60.3% | 11.6% |
| Shares Held by Institutions | 5.77% | 59.4% |
Scores
| Measure | Cocrystal Pharma | Industry median |
|---|---|---|
| Altman Z-Score | -108.69 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Cocrystal Pharma's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.